Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Verona Pharma PLC ADR is a biotechnology business based in the US. Verona Pharma PLC ADR stocks (VRNA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.86 – an increase of 6.92% over the previous week. Verona Pharma PLC ADR employs 24 staff and has a trailing 12-month revenue of around $40 million.
Finder's Pick for
Beginners
Finder's Pick for
Global Trading
Finder's Pick for
Commodity Stocks
Finder's Pick for
Free Trades
| Latest market close | $4.48 |
|---|---|
| 52-week range | $3.41 - $7.25 |
| 50-day moving average | $4.19 |
| 200-day moving average | $5.13 |
| Wall St. target price | $19.83 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.99 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $4.48 from 2022-06-24
| 1 week (2022-06-17) | 6.92% |
|---|---|
| 1 month (2022-05-27) | 4.48 |
| 3 months (2022-03-28) | -10.58% |
| 6 months (2021-12-28) | -36.27% |
| 1 year (2021-06-28) | -33.13% |
|---|---|
| 2 years (2020-06-26) | -11.46% |
| 3 years (2019-06-28) | 5.1 |
| 5 years (2017-06-27) | 12.0697 |
| Revenue TTM | $40 million |
|---|---|
| Gross profit TTM | $40 million |
| Return on assets TTM | -21.09% |
| Return on equity TTM | -39.58% |
| Profit margin | -147.79% |
| Book value | $2.09 |
| Market capitalisation | $266.8 million |
TTM: trailing 12 months
We're not expecting Verona Pharma PLC ADR to pay a dividend over the next 12 months.
Over the last 12 months, Verona Pharma PLC ADR's shares have ranged in value from as little as $3.408 up to $7.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma PLC ADR's is 0.6661. This would suggest that Verona Pharma PLC ADR's shares are less volatile than average (for this exchange).
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. .
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.
Read more…
Here are some investment ideas that could do well despite rising interest rates.
Read more…
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
Read more…Steps to owning and managing ADN stock, with 24-hour and historical pricing before you buy.
Everything we know about the Mobilicom Limited IPO plus information on how to buy in.
Steps to owning and managing XLP stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing SCHH stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing IYK stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing VNQ stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing KIE stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing XLF stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing PXE stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing FCG stock, with 24-hour and historical pricing before you buy.
